Eastman Chemical Company (EMN)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NYSE
Market Cap: $7.43B
Last updated: Nov 17, 2026 at 11:05 AM ET
Eastman Chemical Company (EMN) Financials: Revenue, Profit and Cash Flow
Eastman Chemical Company reported revenue of $8.75B for the fiscal year ended Dec 31, 2025, down 6.7% from the year before. That year, net income was $475.00M with a net margin of 5.4%, operating cash flow was $970.00M and free cash flow was $424.00M. The quarter ended Sep 30, 2026 had revenue of $2.38B and net income of $253.00M.
Revenue and Margins
The operating margin was 8.9% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue fell from $9.01B, a compound annual decline of 0.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $8.75B | -6.7% | 21.1% | 8.9% | 5.4% |
| Dec 2024 | $9.38B | +1.9% | 24.4% | 13.6% | 9.7% |
| Dec 2023 | $9.21B | -12.9% | 22.4% | 14.1% | 9.7% |
| Dec 2022 | $10.58B | +1.0% | 20.2% | 11.0% | 7.5% |
| Dec 2021 | $10.48B | +23.6% | 23.9% | 12.2% | 8.3% |
| Dec 2020 | $8.47B | -8.6% | 23.3% | 10.2% | 5.8% |
| Dec 2019 | $9.27B | -8.6% | 24.1% | 12.1% | 8.2% |
| Dec 2018 | $10.15B | +6.3% | 24.4% | 14.6% | 10.7% |
| Dec 2017 | $9.55B | +6.0% | 24.7% | 14.7% | 14.5% |
| Dec 2016 | $9.01B | N/A | 26.2% | 15.3% | 9.5% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 47.7% from the year before. In the quarter ended Sep 2026, net income rose 266.7% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.75B | $9.38B | $9.21B | $10.58B | $10.48B | $8.47B | $9.27B | $10.15B | $9.55B | $9.01B |
| Cost of revenue | $6.91B | $7.09B | $7.15B | $8.44B | $7.98B | $6.50B | $7.04B | $7.67B | $7.19B | $6.65B |
| Gross profit | $1.84B | $2.29B | $2.06B | $2.14B | $2.50B | $1.98B | $2.23B | $2.48B | $2.36B | $2.36B |
| Research and development | $255.00M | $250.00M | $239.00M | $264.00M | $254.00M | $226.00M | $234.00M | $235.00M | $227.00M | $223.00M |
| Operating income | $776.00M | $1.28B | $1.30B | $1.16B | $1.28B | $868.00M | $1.12B | $1.48B | $1.40B | $1.38B |
| Net income | $475.00M | $908.00M | $896.00M | $796.00M | $867.00M | $489.00M | $762.00M | $1.08B | $1.39B | $859.00M |
| EBITDA | $1.29B | $1.79B | $2.12B | $1.59B | $1.70B | $1.31B | $1.73B | $2.16B | $2.12B | $1.97B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.38B | $2.51B | $2.18B | $1.97B | $2.20B | $2.29B | $2.29B | $2.25B | $2.46B | $2.36B | $2.31B | $2.21B |
| Gross profit | $532.00M | $560.00M | $431.00M | $338.00M | $433.00M | $506.00M | $567.00M | $554.00M | $605.00M | $599.00M | $532.00M | $464.00M |
| Operating income | $305.00M | $311.00M | $188.00M | $64.00M | $188.00M | $222.00M | $302.00M | $349.00M | $329.00M | $337.00M | $263.00M | $477.00M |
| Net income | $253.00M | $184.00M | $107.00M | $105.00M | $69.00M | $140.00M | $183.00M | $331.00M | $181.00M | $231.00M | $165.00M | $311.00M |
Balance Sheet
As of Dec 2025, total debt of $4.79B exceeded cash and equivalents by $4.22B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $14.86B | $15.21B | $14.63B | $14.67B | $15.52B | $16.08B | $16.01B | $15.99B | $10.32B | $15.46B |
| Current assets | $3.65B | $4.10B | $3.48B | $3.78B | $4.65B | $3.54B | $3.32B | $3.37B | $191.00M | $2.87B |
| Cash and equivalents | $566.00M | $837.00M | $548.00M | $493.00M | $459.00M | $564.00M | $204.00M | $226.00M | $191.00M | $181.00M |
| Total liabilities | $8.82B | $9.36B | $9.10B | $9.43B | $9.73B | $9.97B | $9.98B | $10.12B | $0 | $10.85B |
| Short-term debt | $586.00M | $450.00M | $541.00M | $1.13B | $747.00M | $349.00M | $171.00M | $243.00M | $393.00M | $283.00M |
| Long-term debt | $4.20B | $4.57B | $4.30B | $4.03B | $4.41B | $5.27B | $5.61B | $5.92B | $6.15B | $6.31B |
| Shareholder equity | $5.96B | $5.78B | $5.46B | $5.15B | $5.70B | $6.02B | $5.96B | $5.80B | $6.59B | $4.53B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $15.47B | $15.42B | $15.22B | $14.86B | $14.98B | $15.22B | $14.97B | $15.21B | $15.06B | $14.95B | $14.75B | $14.63B |
| Total liabilities | $9.13B | $9.25B | $9.14B | $8.82B | $9.14B | $9.31B | $9.03B | $9.36B | $9.33B | $9.25B | $9.14B | $9.10B |
| Cash and equivalents | $768.00M | $691.00M | $665.00M | $566.00M | $489.00M | $423.00M | $418.00M | $837.00M | $622.00M | $514.00M | $499.00M | $548.00M |
| Shareholder equity | $6.28B | $6.10B | $6.01B | $5.96B | $5.77B | $5.83B | $5.87B | $5.78B | $5.65B | $5.63B | $5.54B | $5.46B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 43.7% of operating cash flow. Dividends and share repurchases together came to 113.4% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $970.00M | $1.29B | $1.37B | $975.00M | $1.62B | $1.46B | $1.50B | $1.54B | $1.66B | $1.39B |
| Capital expenditures | $546.00M | $599.00M | $828.00M | $611.00M | $578.00M | $396.00M | $431.00M | $528.00M | $649.00M | $626.00M |
| Free cash flow | $424.00M | $688.00M | $546.00M | $364.00M | $1.04B | $1.06B | $1.07B | $1.01B | $1.01B | $759.00M |
| Dividends paid | $381.00M | $379.00M | $376.00M | $381.00M | $375.00M | $358.00M | $343.00M | $318.00M | $296.00M | $280.00M |
| Share repurchases | $100.00M | $300.00M | $150.00M | $1.00B | $1.00B | $60.00M | $325.00M | $400.00M | $350.00M | $145.00M |
| Investing cash flow | -$462.00M | -$534.00M | -$432.00M | $392.00M | -$29.00M | -$394.00M | -$480.00M | -$463.00M | -$643.00M | -$655.00M |
| Financing cash flow | -$797.00M | -$454.00M | -$888.00M | -$1.32B | -$1.69B | -$704.00M | -$1.04B | -$1.04B | -$1.01B | -$838.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $290.00M | $224.00M | -$137.00M | $502.00M | $402.00M | $233.00M | -$167.00M | $540.00M | $396.00M | $367.00M | -$16.00M | $452.00M |
| Capital expenditures | $95.00M | $100.00M | $103.00M | $112.00M | $137.00M | $150.00M | $147.00M | $179.00M | $120.00M | $115.00M | $185.00M | $175.00M |
| Free cash flow | $195.00M | $124.00M | -$240.00M | $390.00M | $265.00M | $83.00M | -$314.00M | $361.00M | $276.00M | $252.00M | -$201.00M | $277.00M |
Frequently Asked Questions About EMN
What is Eastman Chemical Company's annual revenue?
Eastman Chemical Company reported revenue of $8.75B for the fiscal year ended Dec 31, 2025.
How fast is Eastman Chemical Company's revenue growing?
Revenue was down 6.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -6.1%.
Is Eastman Chemical Company profitable?
Yes. Eastman Chemical Company reported net income of $475.00M for the fiscal year ended Dec 31, 2025, with a net margin of 5.4%.
How much free cash flow does EMN generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $970.00M minus capital expenditures of $546.00M produced free cash flow of $424.00M.
How much debt does Eastman Chemical Company have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $4.20B, short-term debt of $586.00M and cash and equivalents of $566.00M.
EMN pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors